
-
Trump hails Putin summit but no specifics on Ukraine
-
El Salvador extends detention of suspected gang members
-
Scotland's MacIntyre fires 64 to stay atop BMW Championship
-
Colombia's Munoz fires 59 to grab LIV Golf Indy lead
-
Alcaraz survives Rublev to reach Cincy semis as Rybakina topples No. 1 Sabalenka
-
Trump offers warm welcome to Putin at high-stakes summit
-
Semenyo racist abuse at Liverpool shocks Bournemouth captain Smith
-
After repeated explosions, new test for Musk's megarocket
-
Liverpool strike late to beat Bournemouth as Jota remembered in Premier League opener
-
Messi expected to return for Miami against Galaxy
-
Made-for-TV pageantry as Trump brings Putin in from cold
-
Coman bids farewell to Bayern before move to Saudi side Al Nassr
-
Vietnamese rice grower helps tackle Cuba's food shortage
-
Trump, Putin shake hands at start of Alaska summit
-
Coman bids farewell to Bayern ahead of Saudi transfer
-
Liverpool honour Jota in emotional Premier League curtain-raiser
-
Portugal wildfires claim first victim, as Spain on wildfire alert
-
Davos founder Schwab cleared of misconduct by WEF probe
-
Rybakina rips No.1 Sabalenka to book Cincinnati semi with Swiatek
-
Trump lands in Alaska for summit with Putin
-
Falsehoods swirl around Trump-Putin summit
-
US retail sales rise amid limited consumer tariff hit so far
-
Liverpool sign Parma teenager Leoni
-
Canadian football teams will hit the road for 2026 World Cup
-
Bethell to become England's youngest cricket captain against Ireland
-
Marc Marquez seeks elusive first win in Austria
-
Trump, Putin head for high-stakes Alaska summit
-
Brazil court to rule from Sept 2 in Bolsonaro coup trial
-
Deadline looms to avert Air Canada strike
-
Spain on heat alert and 'very high to extreme' fire risk
-
Taliban mark fourth year in power in Afghanistan
-
Man City boss Guardiola wants to keep Tottenham target Savinho
-
No Grand Slam Track in 2026 till athletes paid for 2025: Johnson
-
Macron decries antisemitic 'hatred' after memorial tree cut down
-
'Doomsday' monsoon rains lash Pakistan, killing almost 200 people
-
Arteta hits back at criticism of Arsenal captain Odegaard
-
Leeds sign former Everton striker Calvert-Lewin
-
'Obsessed' Sesko will star for Man Utd says Amorim
-
Deadly monsoon rains lash Pakistan, killing nearly 170
-
Lyles hints at hitting Olympic form before Thompson re-match
-
Italian authorities try to identify Lampedusa capsize victims
-
UK king, Starmer lead VJ Day tributes to WWII veterans, survivors
-
South Korean president vows to build 'military trust' with North
-
Macron vows to punish antisemitic 'hatred' after memorial tree cut down
-
Hodgkinson happy to be back on track ahead of Tokyo worlds
-
Deadly monsoon rains lash Pakistan, killing dozens
-
Frank urges 'real' Spurs fans to back Tel after racist abuse
-
Japan's emperor expresses 'deep remorse' 80 years after WWII
-
Chelsea boss Maresca eager to sign new defender as Colwill cover
-
Liverpool target Isak controls his Newcastle future: Howe

US overdose capital Baltimore on long road to recovery
Carrying a bag filled with the overdose-reversing drug naloxone, Adam Trionfo roams the brick-lined streets of one of America's oldest port cities, Baltimore.
The 40-year-old and his small team visit neighborhoods considered "hot spots" for drug trafficking to hand out the precious antidote, sold under the brand name Narcan.
The easy-to-use nasal spray has become a key tool in the fight against the deadly US opioid crisis, claiming 750,000 lives between the late 1990s and 2022.
"Just over the past week, we distributed 200 Narcan kits," Trionfo, who oversees an addiction assistance program with the local branch of Catholic Charities, told AFP.
On their route, the team spots a man sprawled out amid a pile of rubbish in the corner of a stairwell. They hand him a box of Narcan and a brochure about their organization.
The man takes it with one hand, as he awkwardly hides a syringe behind his back.
Their last Narcan kit goes to another man, legs covered in brown scars, who is waiting near a dilapidated building.
These scenes are not uncommon in this East Coast city, which is located about 50 kilometers (31 miles) from Washington and is renowned for endemic crime.
Baltimore was the setting of the hit television series "The Wire" in the early 2000s, depicting its burgeoning drug scene from a variety of angles.
And last year, the New York Times dubbed the city the "American overdose capital."
Between 2018 and 2022, the drug-related mortality rate was nearly twice as high as in any other major American city. The leading killer: fentanyl.
- 'Tremendous efforts' -
Since the height of the opioid crisis in 2021, the outlook has improved in much of the country, including in Baltimore.
The number of fatal overdoses in the city plummeted by 35 percent last year, to 680 down from 1,043 in 2023.
The city's proactive policies, coupled with preventative work done by Catholic charities in Baltimore's communities have helped make a dent in the problem.
"We've had tremendous efforts throughout the city to get people into treatment, and then we've also had tremendous efforts in getting Naloxone out there," said Michael Fingerhood, head of addiction medicine at Johns Hopkins Bayview Medical Center.
Distributed broadly for about a decade, Narcan has worked like a "fire extinguisher," Fingerhood said.
In Baltimore, Narcan is now available everywhere: pharmacies, vending machines throughout the city, even in libraries.
- Funded by restitution -
The drop in mortality in Baltimore is also linked to the composition of the fentanyl being sold there, Fingerhood said.
"The drug supply has less potent fentanyl and has additives that are less likely to cause overdose."
Awareness of the risks associated with the powerful synthetic opioid has also grown among users, pushing them to be more "cautious," said Bakari Atiba, community engagement director at Charm City Care Connection.
The nonprofit assists addicts in Baltimore -- known as Charm City -- and recently received funding from a restitution program fueled by lawsuits against opioid manufacturers and distributors.
"I'm not saying people are going to stop using," Atiba said. "That's not even our goal."
"It's about meeting people where they are, making sure they're safe, making sure they're supported, and making sure they have pathways to recovery if they want it."
H.Kuenzler--VB